Skip to main content
Erschienen in: Clinical Hypertension 1/2021

Open Access 01.12.2021 | Research

Prevalence, awareness, and control of hypertension among Bangladeshi adults: an analysis of demographic and health survey 2017–18

verfasst von: Gulam Muhammed Al Kibria, Rajat Das Gupta, Jannatun Nayeem

Erschienen in: Clinical Hypertension | Ausgabe 1/2021

Abstract

Background

The prevalence of hypertension is increasing in Bangladesh, however, few recent studies investigated the proportion of people and factors associated with prevalence, awareness, and control of this condition in this country. This study investigated these among Bangladeshi adults.

Methods

Using Bangladesh Demographic and Health Survey 2017–18 data, a cross-sectional study was conducted. Multilevel logistic regression analysis was employed after descriptive analysis and prevalence estimation.

Results

Among 12,926 persons (mean age: 40 years, 57% women), the prevalence of hypertension was 27.4% (n = 3551), it was 28.4 and 26.2% among females and males, respectively. Among hypertensive people, about 42.4% (n = 1508) people were aware of having it, 48.7% among females and 33.5% among males. Of the 1313 people who were taking antihypertensive medication, only 33.8% (n = 443) had controlled hypertension, 34.7 and 31.7% among females and males, respectively.
Among the studied factors associated with hypertension, people with older age, female gender, overweight/obesity, diabetes, richer wealth quintiles, and residence in some administrative divisions had higher odds of hypertension (p < 0.05). However, the odds of awareness was lower among younger people, males, and people without overweight/obesity, diabetes, or richer wealth quintiles. Odds of controlled hypertension was also lower among people with older age and higher among college-educated people.

Conclusion

This study identified several important factors associated with prevalence, awareness, and control of hypertension. It is important to address these factors with nationwide prevention and control programs.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s40885-021-00174-2.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AOR
Adjusted odds ratio
BP
Blood pressure
BDHS
Bangladesh Demographic and Health Survey
BMI
Body mass index
DBP
Diastolic blood pressure
LMIC
Low- and middle-income countries
SBP
Systolic blood pressure
SE
Standard errors
UOR
Unadjusted odds ratio

Background

Hypertension is a leading risk factor for cardiovascular disease and a major cause of deaths and disabilities among adults worldwide [1, 2]. Recent trends suggest that the prevalence of hypertension is increasing at an alarming rate among people in low- and middle-income countries (LMICs) [2]. Bangladesh, an LMIC in South Asia, is of no exception from this rising trend [3, 4]. According to the latest Bangladesh Demographic and Health Survey (BDHS) 2017–18, a nationally representative survey from Bangladesh, about 45% of the women and 34% of the men aged 35 years and older are hypertensive in this country [4]. This is a significant rise from the previous estimates of 32 and 20% among women and men of same age group in 2011, respectively [4, 5]. The ongoing demographic transition with an increasing proportion of aging population along with changes in socioeconomic status, lifestyles, and dietary habits of Bangladeshi people could contribute to this higher prevalence [2, 46]. This report also shows that more than half of the hypertensive people are not aware of their hypertensive condition [4].
It is important to halt this continues rise in prevalence of hypertension in this country. In addition, to reduce future burden of complications resulting from hypertension, increasing the awareness of hypertension among those who are hypertensive and increasing the control of blood pressure (BP) among those who take any antihypertensive drugs are important [2, 7]. Therefore, identifying the determinants or associated factors of prevalence, awareness, and control of hypertension and addressing them with prevention programs are critical. Using BDHS 2011 data, multiple previous studies reported that people with older age, female gender, urban residence, and higher education level or wealth status had higher prevalence of hypertension [3, 6, 810]. These factors may also contribute to awareness and control [7, 11]. However, the proportion of people with prevalence, awareness, or control of hypertension according to background characteristics and factors associated with these three outcomes in recent years are not known. In this study, using a nationally representative sample of Bangladeshi adults, we attempted to estimate prevalence, awareness, and control of hypertension along with the factors that influence these three outcomes.

Methods

Study design and setting

We conducted a cross-sectional study by performing secondary analysis on BDHS 2017–18 data. This is the eighth nationwide survey to report major demographic and health indicators on the country. Data collection took place from October 2017 to March 2018. Mitra and Associates, a private research firm in Bangladesh, implemented it [4]. We analyzed the data in January 2021.
A two-stage stratified sample of households was selected. First, for the sampling frame, a list of enumeration areas (EAs) was prepared from the 2011 Population and Housing Census of the People’s Republic of Bangladesh, 250 and 425 EAs from urban and rural areas, respectively. EA was the primary sampling unit and was selected with probability proportional to size. In the EA, a complete list of all the households were done. Then, in the second stage, an average of 30 households were selected from each EA. A total of 20,250 households were selected in this way. From these households, one-fourth of the households were randomly selected for BP and fasting plasma glucose measurements. All adults (i.e., 18 years of age or older) living in these households were invited to participate for measuring BP and fasting plasma glucose. Among 14,704 eligible women and men, about 90% participated. The quality of data collection was monitored by 4 quality control teams from the data collection organization. The questionnaires were translated and validated in the context of Bangladesh. Details of BDHS 2017–18, including survey design, methodologies, sample size calculation, questionnaires, and other statistics are available elsewhere [4].

Outcome variables

The outcome measures of this study were ‘prevalence (i.e., presence of hypertension) of hypertension’, ‘awareness of having hypertension’ and ‘controlled hypertension among those who take antihypertensive drug’. Systolic BP (SBP) and diastolic BP (DBP) were measured for three times (in millimeters of mercury [mmHg]) with an interval of five minutes between measurements. BP was recorded by digital oscillometric BP device (i.e., LIFE SOURCE® UA-767 Plus BP monitor). Appropriate cuff sizes were used [4]. The mean of the last two measurements was used to classify a respondent as hypertensive. If the third measurement was not available, then the second measurement was used. In case of missing second and third measurements, the first measurement was used. Similar to BDHS 2017–18, we used World Health Organization - International Society of Hypertension cutoffs to classify a person as hypertensive [4, 12]. Therefore, a person with an SBP/DBP of 140/90 mmHg or more was categorized as hypertensive. In addition, participants who reported that they were taking any BP lowering drugs were considered as hypertensive [12].
Among those we found hypertensive, we considered a person as aware if the person knew the diagnosis of hypertension from a doctor or nurse (i.e., “Have you ever been told by a doctor or other health worker that you have high BP or hypertension?”) [4]. Among those who were taking any antihypertensive drugs, we considered ‘controlled hypertension’ if the person had the SBP/DBP below 140/90 mmHg during the measurement of BP.

Potential determinants/independent variables

Based on published reports and data structure, we investigated age, gender, overweight/obesity, diabetes, education level, wealth quintile, and place and division of residence as potential determinants. Age was categorized into 18–34, 35–44, 45–54, 55–64, and 65 or above years. Overweight/obesity was obtained from body mass index (BMI). BMI was obtained by dividing weight (in Kg) with height (in m2). Body weight was measured using a lightweight, electronic SECA 878 scale screen. Height was obtained with a ShorrBoard® measuring board in standing position [4]. Persons with a BMI 23 Kg/m2 or more were classified as having overweight/obesity [13, 14]. Fasting plasma glucose was measured using HemoCue 201 RT analyzer [4]. We classified a participant as diabetic if the fasting plasma glucose was 7 mmol/l or more. People who were taking antidiabetic drugs were also considered as diabetic. Participants reported their gender (i.e., male or female) and place (i.e., rural or urban) and division (i.e., Barishal, Chattagram, Dhaka, Khulna, Mymensingh, Rajshahi, Rangpur, or Sylhet) of residence. Education level was categorized into no formal education, primary (i.e., 1–5 school years), secondary (i.e., 6–10 school years), and college or above (i.e., 11 or more school years). Wealth status was obtained from household belongings and basic household construction materials. Similar to previous BDHS, principal component analysis was used to obtain a wealth index score from those components and was then stratified into quintiles: poorest, poorer, middle, richer, and richest [4, 15].

Statistical analysis

First, we described the study sample with weighted numbers and percentages for categorical variables and means and standard errors (SE) for continuous variables according to the prevalence, awareness, and control status (Tables 1, 2, and 3). To compare continuous variables, we used t-tests and to compare categorical variables, we used chi-square tests. We also reported the prevalence, awareness, and controlled hypertension according to the study variables (Table 4). We have also reported the prevalence among people 30 years of age (Supplemental Table 1). We then obtained the unadjusted odds ratios (UOR) along with 95% confidence intervals (CI) using multilevel logistic regression (Supplemental Table 2). Multilevel regression was done due to the hierarchical nature of the BDHS data (Table 5). Variables with a significance level (i.e., p-values) up to 0.2 were investigated into multivariable models to obtain the adjusted OR (AOR) [16]. We obtained variance inflation factors (VIF) with a fake linear regression model to check multicollinearity. We used the provided sample weights to obtain all estimates [4]. Stata 14.0 (College Station, TX, USA) was used to analyze data [17].
Table 1
Distribution of the study sample according to presence of hypertension
Variables
Total (n = 12,926)
Hypertension
Yes (n = 3551)
No (n = 9375)
p-value
Mean systolic BP (SE), mmHg
122.3 (0.25)
145.8 (0.42)
113.5 (0.15)
< 0.001
Mean diastolic BP (SE), mmHg
80.2 (0.14)
91.5 (0.21)
76.0 (0.11)
< 0.001
Age (in years)
 Mean (SE)
39.6 (0.15)
49.0 (0.30)
36.2 (0.17)
< 0.001
 18 to 34
5787 (44.8)
738 (20.8)
5049 (53.9)
< 0.001
 35 to 44
2585 (20)
735 (20.7)
1850 (19.7)
 
 45 to 54
1815 (14)
698 (19.7)
1116 (11.9)
 
 55 to 64
1454 (11.3)
680 (19.1)
775 (8.3)
 
 65 or more
1285 (9.9)
700 (19.7)
585 (6.2)
 
Gender
 Female
7343 (56.8)
2088 (58.8)
5255 (56.1)
0.01
 Male
5583 (43.2)
1463 (41.2)
4120 (43.9)
 
Diabetes
 Mean fasting plasma glucose (SE), mmol/L
5.7 (0.02)
6.0 (0.05)
5.6 (0.02)
< 0.001
 No
10,893 (90.1)
2786 (83.4)
8107 (92.6)
< 0.001
 Yes
1199 (9.9)
553 (16.6)
646 (7.4)
 
Overweight/Obesity
 Mean body mass index (SE), Kg/m2
22.4 (0.06)
23.7 (0.09)
21.9 (0.06)
< 0.001
 No
7640 (59.8)
1573 (45.2)
6067 (65.3)
< 0.001
 Yes
5129 (40.2)
1904 (54.8)
3225 (34.7)
 
Education level
 No formal education
3444 (26.6)
1211 (34.1)
2233 (23.8)
< 0.001
 Primary
3839 (29.7)
1047 (29.5)
2792 (29.8)
 
 Secondary
3790 (29.3)
877 (24.7)
2914 (31.1)
 
 College or above
1853 (14.3)
416 (11.7)
1437 (15.3)
 
Wealth quintile
 Poorest
2459 (19.0)
584 (16.4)
1875 (20)
< 0.001
 Poorer
2534 (19.6)
638 (18)
1897 (20.2)
 
 Middle
2635 (20.4)
705 (19.8)
1930 (20.6)
 
 Richer
2560 (19.8)
723 (20.4)
1837 (19.6)
 
 Richest
2738 (21.2)
902 (25.4)
1836 (19.6)
 
Place of residence
 Urban
3542 (27.4)
1009 (28.4)
2533 (27)
0.19
 Rural
9383 (72.6)
2542 (71.6)
6842 (73)
 
Division of residence
 Dhaka
3096 (23.9)
730 (20.5)
2366 (25.2)
< 0.001
 Barishal
718 (5.6)
234 (6.6)
484 (5.2)
 
 Chattagram
2237 (17.3)
666 (18.8)
1571 (16.8)
 
 Khulna
1586 (12.3)
474 (13.3)
1113 (11.9)
 
 Mymensingh
1067 (8.3)
252 (7.1)
815 (8.7)
 
 Rajshahi
1829 (14.2)
503 (14.2)
1326 (14.1)
 
 Rangpur
1552 (12)
473 (13.3)
1079 (11.5)
 
 Sylhet
840 (6.5)
220 (6.2)
621 (6.6)
 
SE Standard error
Table 2
Description of study sample according to awareness among those with hypertension
Variables
Total (n = 3551)
Awareness
Yes (n = 1508)
No (n = 2043)
p-value
Mean Systolic BP (SE), mmHg
145.8 (0.43)
148.0 (0.77)
144.0 (0.42)
< 0.001
Mean diastolic BP (SE), mmHg
91.5 (0.21)
90.8 (0.37)
92.0 (0.21)
0.004
Age (in years)
 Mean (SE)
49.0 (0.30)
52.1 (0.41)
46.8 (0.41)
< 0.001
 18 to 34
738 (20.8)
214 (14.2)
524 (25.6)
< 0.001
 35 to 44
735 (20.7)
275 (18.3)
460 (22.5)
 
 45 to 54
698 (19.7)
320 (21.2)
379 (18.5)
 
 55 to 64
680 (19.1)
361 (23.9)
319 (15.6)
 
 65 or more
700 (19.7)
338 (22.4)
362 (17.7)
 
Gender
 Female
2088 (58.8)
1018 (67.5)
1070 (52.4)
< 0.001
 Male
1463 (41.2)
490 (32.5)
973 (47.6)
 
Diabetes
 Mean fasting plasma glucose (SE), mmol/L
6.0 (0.05)
6.2 (0.07)
5.9 (0.06)
< 0.001
 No
2786 (83.4)
1104 (77.7)
1682 (87.7)
< 0.001
 Yes
553 (16.6)
316 (22.3)
237 (12.3)
 
Overweight/Obesity
 Mean body mass index (SE), Kg/m2
23.7 (0.09)
24.4 (0.13)
23.2 (0.12)
< 0.001
 No
1573 (45.2)
572 (38.7)
1001 (50.1)
< 0.001
 Yes
1904 (54.8)
905 (61.3)
999 (49.9)
 
Education level
 No Formal Education
1211 (34.1)
524 (34.7)
687 (33.6)
0.27
 Primary
1047 (29.5)
456 (30.3)
591 (28.9)
 
 Secondary
877 (24.7)
369 (24.5)
507 (24.8)
 
 College or above
416 (11.7)
158 (10.5)
258 (12.6)
 
Wealth Quintile
 Poorest
584 (16.4)
190 (12.6)
394 (19.3)
< 0.001
 Poorer
638 (18.0)
232 (15.4)
406 (19.8)
 
 Middle
705 (19.8)
295 (19.6)
410 (20.0)
 
 Richer
723 (20.4)
333 (22.1)
390 (19.1)
 
 Richest
902 (25.4)
458 (30.4)
444 (21.7)
 
Place of residence
 Urban
1009 (28.4)
470 (31.2)
539 (26.4)
0.006
 Rural
2542 (71.6)
1037 (68.8)
1505 (73.6)
 
Division of Residence
 Dhaka
730 (20.5)
332 (22.0)
398 (19.5)
0.005
 Barishal
234 (6.6)
104 (6.9)
130 (6.4)
 
 Chattagram
666 (18.8)
296 (19.7)
370 (18.1)
 
 Khulna
474 (13.3)
208 (13.8)
266 (13.0)
 
 Mymensingh
252 (7.1)
107 (7.1)
145 (7.1)
 
 Rajshahi
503 (14.2)
196 (13.0)
307 (15.0)
 
 Rangpur
473 (13.3)
157 (10.4)
316 (15.5)
 
 Sylhet
220 (6.2)
107 (7.1)
112 (5.5)
 
Number are presented along with column percentage unless otherwise specified
Table 3
Controlled hypertension status among those taking antihypertensive drugs
Variables
Overall (n = 1313)
Controlled Hypertension
Yes (n = 443)
No (n = 870)
p-values
Mean systolic BP (SE), mmHg
147.1 (0.82)
121.7 (0.57)
160.0 (0.83)
< 0.001
Mean diastolic BP (SE), mmHg
89.8 (0.39)
79.3 (0.39)
95.2 (0.41)
< 0.001
Age (in years)
Mean (SE)
52.7 (0.42)
48.7 (0.75)
54.7 (0.51)
< 0.001
18 to 34
163 (12.4)
88 (19.8)
75 (8.6)
< 0.001
35 to 44
236 (17.9)
90 (20.3)
145 (16.7)
 
45 to 54
287 (21.9)
91 (20.5)
196 (22.5)
 
55 to 64
328 (25.0)
109 (24.6)
219 (25.1)
 
65 or more
300 (22.8)
65 (14.7)
235 (27.0)
 
Gender
Female
893 (68.0)
310 (70.0)
583 (67.0)
0.32
Male
420 (32.0)
133 (30.0)
287 (33.0)
 
Diabetes
Mean fasting plasma glucose (SE), mmol/L
6.3 (0.08)
5.9 (0.11)
6.4 (0.10)
0.001
No
948 (76.4)
330 (80.1)
618 (74.6)
0.043
Yes
293 (23.6)
82 (19.9)
211 (25.4)
 
Overweight/Obesity
Mean body mass index (SE), kg/m2
24.4 (0.13)
24.5 (0.22)
24.4 (0.16)
0.69
No
486 (37.8)
168 (38.6)
318 (37.3)
0.67
Yes
801 (62.2)
268 (61.4)
533 (62.7)
 
Education level
No formal education
468 (35.6)
129 (29.2)
338 (38.9)
0.007
Primary
395 (30.1)
136 (30.8)
258 (29.7)
 
Secondary
320 (24.3)
122 (27.6)
197 (22.7)
 
College or above
131 (10.0)
55 (12.5)
76 (8.7)
 
Wealth quintile
Poorest
162 (12.4)
52 (11.7)
110 (12.7)
0.66
Poorer
193 (14.7)
63 (14.3)
129 (14.9)
 
Middle
263 (20.0)
84 (18.9)
179 (20.6)
 
Richer
289 (22.0)
110 (24.7)
179 (20.6)
 
Richest
407 (31.0)
135 (30.4)
272 (31.3)
 
Place of residence
Urban
417 (31.8)
150 (33.9)
267 (30.7)
0.28
Rural
896 (68.2)
293 (66.1)
603 (69.3)
 
Division of residence
Dhaka
297 (22.6)
98 (22.1)
199 (22.9)
< 0.001
Barishal
92 (7.0)
32 (7.2)
60 (6.8)
 
Chattagram
273 (20.8)
114 (25.7)
159 (18.3)
 
Khulna
173 (13.2)
44 (9.9)
129 (14.8)
 
Mymensingh
98 (7.4)
48 (10.8)
50 (5.8)
 
Rajshahi
153 (11.7)
34 (7.6)
119 (13.7)
 
Rangpur
126 (9.6)
35 (7.9)
91 (10.4)
 
Sylhet
101 (7.7)
39 (8.8)
62 (7.2)
 
SE Standard error
Table 4
Prevalence (95% confidence interval) of people with hypertension, awareness, and control
Category
Hypertension
Awareness among hypertensive people
Controlled pressure people taking antihypertensive drugs
Overall
27.4 (26.5, 28.5)
42.4 (40.5, 44.4)
33.8 (30.8, 36.8)
Age (in year)
 18 to 34
12.7 (11.8, 13.8)
29.0 (25.6, 32.7)
54.0 (45.1, 62.7)
 35 to 44
28.4 (26.6, 30.3)
37.4 (33.3, 41.7)
38.3 (31.5, 45.6)
 45 to 54
38.5 (35.6, 41.4)
45.8 (41.6, 50.0)
31.7 (26.2, 37.8)
 55 to 64
46.7 (44.0, 49.5)
53.1 (49.3, 56.8)
33.3 (27.9, 39.2)
 65 or more
54.5 (51.5, 57.4)
48.3 (44.4, 52.1)
21.7 (17.5, 26.5)
Gender
 Female
28.4 (27.3, 29.6)
48.7 (46.3, 51.2)
34.7 (31.2, 38.4)
 Male
26.2 (24.8, 27.7)
33.5 (30.8, 36.2)
31.7 (27.0, 36.8)
Diabetes
 No
25.6 (24.6, 26.6)
39.6 (37.5, 41.8)
34.8 (31.4, 38.4)
 Yes
46.1 (42.7, 49.6)
57.2 (52.4, 61.9)
28.0 (22.7, 34.0)
Overweight/Obese
 No
20.6 (19.5, 21.7)
36.3 (33.8, 39)
34.6 (30.3, 39.2)
 Yes
37.1 (35.6, 38.7)
47.5 (45, 50.1)
33.4 (29.7, 37.3)
Education level
 No formal education
35.2 (33.2, 37.1)
43.2 (40.0, 46.6)
27.7 (23.3, 32.5)
 Primary
27.3 (25.7, 29.0)
43.6 (40.3, 46.9)
34.5 (29.4, 40.1)
 Secondary
23.1 (21.6, 24.7)
42.1 (38.5, 45.8)
38.3 (32.0, 44.9)
 College or above
22.5 (20.4, 24.7)
38.0 (33.8, 42.5)
42.1 (33.9, 50.8)
Wealth quintile
 Poorest
23.7 (21.9, 25.7)
32.5 (28.2, 37.1)
32.0 (24.2, 41.0)
 Poorer
25.2 (23.1, 27.3)
36.4 (32.3, 40.7)
32.8 (26.2, 40.2)
 Middle
26.7 (24.7, 28.8)
41.9 (37.7, 46.1)
31.9 (25.1, 39.5)
 Richer
28.2 (26.1, 30.5)
46.0 (42.0, 50.1)
38.0 (31.9, 44.6)
 Richest
32.9 (31.0, 34.9)
50.8 (47.0, 54.5)
33.1 (28.5, 38.0)
Place of residence
 Urban
28.5 (26.8, 30.2)
46.6 (43.3, 50.0)
36.0 (31.3, 41.0)
 Rural
27.1 (25.9, 28.3)
40.8 (38.4, 43.2)
32.7 (29.1, 36.5)
Division of residence
 Dhaka
23.6 (21.4, 25.9)
45.4 (40.5, 50.5)
32.9 (26.2, 40.5)
 Chattagram
29.8 (27.2, 32.4)
44.5 (39.5, 49.6)
41.7 (34.4, 49.4)
 Barishal
32.6 (29.5, 35.9)
44.4 (39.0, 50.0)
35.0 (26.5, 44.6)
 Khulna
29.9 (27.2, 32.7)
43.9 (38.7, 49.3)
25.4 (19.7, 32.0)
 Mymensingh
23.6 (21.2, 26.2)
42.3 (36.0, 48.8)
48.7 (39.7, 57.9)
 Rajshahi
27.5 (24.8, 30.4)
39.1 (34.0, 44.3)
22.1 (15.8, 29.9)
 Rangpur
30.5 (28.3, 32.7)
33.2 (28.6, 38.2)
27.7 (20.5, 36.3)
 Sylhet
26.1 (23.5, 29.0)
48.9 (42.4, 55.4)
38.5 (30.2, 47.5)
Table 5
Results of logistic regression analysis to investigate adjusted odds ratio (with 95% confidence interval) for the factors associated with prevalence of hypertension, awareness among hypertensive people, and controlled hypertension among people taking antihypertensive drugs
Variable
Prevalence
Awareness
Controlled hypertension
AOR
p-value
AOR
p-value
AOR
p-value
Age (in year)
 18 to 34
Ref. (1.0)
Ref. (1.0)
Ref. (1.0)
 35 to 44
2.7 (2.4,3.1)
< 0.001
1.8 (1.4,2.3)
< 0.001
0.5 (0.3,0.8)
0.003
 45 to 54
4.5 (3.9,5.2)
< 0.001
2.8 (2.1,3.6)
< 0.001
0.4 (0.3,0.6)
< 0.001
 55 to 64
7.3 (6.2,8.5)
< 0.001
4.2 (3.2,5.6)
< 0.001
0.4 (0.3,0.7)
< 0.001
 65 or more
11.9 (10.1,14.1)
< 0.001
4.2 (3.2,5.6)
< 0.001
0.3 (0.2,0.5)
< 0.001
Gender
 Female
Ref. (1.0)
Ref. (1.0)
ND
 
 Male
0.8 (0.7,0.8)
< 0.001
0.4 (0.3,0.5)
< 0.001
 
Diabetes
 No
Ref. (1.0)
Ref. (1.0)
Ref. (1.0)
 Yes
1.7 (1.5,1.9)
< 0.001
1.6 (1.3,2.0)
< 0.001
0.7 (0.5,1.0)
0.059
Overweight/Obese
 No
Ref. (1.0)
Ref. (1.0)
ND
 
 Yes
2.5 (2.2,2.7)
< 0.001
1.5 (1.3,1.8)
< 0.001
 
Education level
 No formal education
Ref. (1.0)
Ref. (1.0)
Ref. (1.0)
 Primary
1.1 (0.9,1.2)
0.38
1.2 (1.0,1.5)
0.033
1.1 (0.8,1.5)
0.74
 Secondary
1.0 (0.9,1.2)
0.59
1.3 (1.0,1.7)
0.024
1.2 (0.8,1.7)
0.38
College or above
1.0 (0.9,1.2)
0.44
1.3 (0.9,1.8)
0.076
1.6 (1.1,2.5)
0.027
Wealth quintile
 Poorest
Ref. (1.0)
Ref. (1.0)
ND
 
 Poorer
1.1 (1.0,1.3)
0.13
1.3 (1.0,1.8)
0.054
 
 Middle
1.2 (1.0,1.4)
< 0.001
1.5 (1.1,1.9)
0.006
 
 Richer
1.4 (1.2,1.6)
< 0.001
1.7 (1.3,2.3)
< 0.001
 
 Richest
1.4 (1.2,1.7)
< 0.001
1.7 (1.3,2.3)
< 0.001
 
Place of residence
 Urban
1.0 (0.9,1.2)
0.62
1.1 (0.9,1.4)
0.20
ND
 
 Rural
Ref. (1.0)
Ref. (1.0)
 
Division of residence
 Dhaka
Ref. (1.0)
Ref. (1.0)
Ref. (1.0)
 Chattagram
1.5 (1.2,1.8)
< 0.001
1.0 (0.7,1.4)
0.85
1.4 (0.9,2.3)
0.17
 Barisal
1.6 (1.3,2.0)
< 0.001
1.1 (0.7,1.5)
0.66
0.9 (0.6,1.6)
0.80
 Khulna
1.3 (1.1,1.6)
0.003
1.0 (0.7,1.4)
0.85
0.8 (0.5,1.2)
0.27
 Mymensingh
1.1 (0.9,1.4)
0.44
1.0 (0.7,1.4)
0.90
1.6 (0.9,2.8)
0.079
 Rajshahi
1.4 (1.2,1.7)
0.001
0.9 (0.6,1.2)
0.48
0.6 (0.3,1.0)
0.061
 Rangpur
1.8 (1.5,2.2)
< 0.001
0.8 (0.6,1.2)
0.24
0.7 (0.4,1.3)
0.25
 Sylhet
1.4 (1.1,1.7)
0.006
1.5 (1.0,2.1)
0.038
1.2 (0.7,2.0)
0.44
AOR Adjusted odds ratio, ND Not done, were not adjusted as the unadjusted p-values were more than 0.20

Ethical approval

The Institutional Review Boards (IRBs) of the ICF International, Rockville, Maryland, USA and Bangladesh Medical Research Council, Dhaka, Bangladesh approved the BDHS 2017–18 protocol. The permission for using the data was obtained in December 2020. All participants provided informed consent to participate into the survey.

Results

A total of 12,926 participants were included in the analysis (Table 1). Mean SBP and DBP were 122.3 mmHg (SE: 0.25) and 80.2 mmHg (SE: 0.14), respectively. The average age of the participants was 39.6 years (SE: 0.15) and about 56.8% (n = 7343) of the participants were females; hypertensive people had a higher proportion of older people or females than people without hypertension. About 9.9% (n = 1199) and 40.2% (n = 5129) of the participants had diabetes and overweight/obesity, respectively. About 26.6% of the participants had no formal education or 27.4% of the participants were living in urban areas. The overall proportion of people with diabetes, overweight/obesity, or urban residence was higher among people with hypertension than those without hypertension. About one-fourth of the participants were from Dhaka division, 23.9% (n = 3096).
Among people who were hypertensive (n = 3551), the mean SBP and DBP were 145.8 mmHg (SE: 0.43) and 91.5 mmHg (SE: 0.21), respectively (Table 2). The mean SBP, DBP, age, fasting plasma glucose, and BMI of people with awareness was higher than those without awareness. The proportion of male participants was higher among those without awareness compared to those with it, 47.6% (n = 973) and 32.5% (n = 489), respectively. The awareness level also differs by wealth status and place or division of residence.
Among those who were taking antihypertensive drugs (n = 1313), the mean age and fasting plasma glucose was higher among those who had uncontrolled BP (n = 870) than those who had controlled BP (n = 443) (Table 3). Among all those who were taking antihypertensive, more than two-thirds were females, 68.0% (n = 893), it was similar among those with or without controlled hypertension. About one-fourth had diabetes and two-third had overweight/obesity, 23.6% (n = 293) and 62.2% (n = 801), respectively. Controlled hypertension level did not differ by wealth status or place of residence, however, it differed by education level and division of residence (p < 0.05).
Table 4 shows the prevalence, awareness, and control of hypertension according to background characteristics. The overall prevalence (95% CI) of hypertension was 27.4% (26.5 to 28.5%), it increased with age, 12.7% (11.8 to 13.8%), 28.4% (26.6 to 30.3%), 38.5% (35.6 to 41.4%), 46.7% (44.0 to 49.5%) and 54.5% (51.5 to 57.4%) among people with 18–34, 35–44, 45–54, 55–64, and 65 or more years of age, respectively. Females had a higher prevalence (95% CI) than males, 28.4% (27.3 to 29.6%) and 26.2% (24.8 to 27.7%), respectively. The prevalence also differed according to diabetes, overweight/obesity, education level, wealth status, and place and division of residence. Less than half of the people were aware about hypertensive status, 42.4% (95% CI: 40.5 to 44.4%). More females than males were aware of their hypertensive status, 48.7% (95% CI: 46.3 to 51.2%) and 33.5% (95% CI: 30.8 to 36.2%), respectively. It also differed by overweight/obesity, diabetes, and most other characteristics. About one-third of the people who were taking any antihypertensive drugs had controlled BP, 33.8% (95% CI: 30.8 to 36.8%). It decreased with age. Females had a slightly higher prevalence of controlled BP than males, 34.7% (95% CI: 31.2 to 38.4%) and 31.7% (95% CI: 27.0 to 36.8%), respectively. It also differed by education level and people with a relatively higher education level had a higher prevalence of controlled BP than those with a lower education level.
Table 5 reports the results of multilevel logistic regression to report the factors associated with prevalence, awareness, and control of hypertension. The adjusted odds of having hypertension increased with age. The adjusted odds of hypertension among males were 0.8 (95% CI: 0.7 to 0.8) times the odds among females. Similarly, diabetes (AOR: 1.7, 95% CI: 1.5 to 1.9) and overweight/obesity (AOR: 2.5, 95% CI: 2.2 to 2.7) had significant positive association with hypertension. Factors associated with awareness of hypertension were similar as having hypertension. Older people, people with diabetes or overweight/obesity, higher education level, or wealth status had significantly higher odds of awareness about having hypertension. Lastly, older age was associated with lower odds of controlled hypertension and college or above education level was associated with higher odds of controlled hypertension.

Discussion

In this study, we observed that more than 1 in 4 people in Bangladesh may have hypertension, however, a majority of them were unaware of having it or did not have controlled hypertension despite taking antihypertensive drugs. We also identified several associated factors for these outcomes, including age, gender, having diabetes and overweight/obesity, education, wealth quintiles, and living in several divisions.
The factors that we observed in these study are similar to the factors identified by previous studies that analyzed BDHS 2011 data, however, the age group of BDHS 2017–18 (i.e., 18 years of age or older) is different than BDHS 2011 (i.e., 35 years of age or older) [3, 4, 8, 18]. Among people with 35–44, 45–54, 55–64, and 65 or more years of age, the prevalence of hypertension was 17.1, 25.0, 30.2, and 40.3%, respectively in 2011, but the prevalence was about 1.5 times high within these age groups in our analysis, 28.4, 38.5, 46.7, and 54.5%, respectively [4, 8]. The awareness level and control remained similar. As mentioned, one major finding is that within less than a decade (i.e., from 2011 to 2017–18), among people with 35 years of age or older, the prevalence rose by more than 1.5 times, this signifies having national prevention and control programs [4]. Bangladesh and many other developing countries are currently facing double disease burden with a simultaneous higher burden of infectious and noninfectious diseases [19]. Multiple non-communicable disease programs were implemented in Bangladesh. However, those programs had inadequate planning, implementation, and monitoring to make them successful [20]. Apart from hypertension, the prevalence of many other chronic diseases (e.g., diabetes and overweight/obesity) has also increased [4]. The substantial rise in prevalence within this short period also indicates a little success of those programs. Therefore, we recommend implementing new prevention and control programs by addressing all the studied factors we identified.
We found positive association of age with prevalence and awareness of hypertension, though it was in opposite direction for hypertension control. Age is a known non-modifiable risk factor for hypertension [21]. With increasing age, structural changes take place in blood vessel walls and the risk for hypertension increases due to stiffness, sodium consumption, lack of dietary potassium, and physical inactivity [21, 22]. Older people also have increased risks for many other chronic conditions such as diabetes, overweight/obesity, chronic kidney disease, and other cardiac diseases that may impact the BP control [3, 21, 23, 24]. These diseases influence the outcome of one another, share many common risk factors, and may cause more severe complications [3, 21]. Overall, all age groups had lower awareness and control levels. Although we found a lower prevalence of hypertension among younger (i.e., less than 35-year-old) people, an overwhelming majority of them did not have awareness about it [4]. Having awareness and control from a relatively younger age are more beneficial to reduce future complications of hypertension [7, 21]. Moreover, adopting healthier lifestyle and dietary habits from younger age may not only reduce the future risks of it but also other chronic diseases mentioned above [21].
Gender was not associated with hypertension control, although the prevalence of hypertension was slightly lower among males, they had significantly lower awareness level. Previous studies in Bangladesh had similar findings [3, 810]. Though little is known about gender differences in pathophysiology of hypertension in Bangladesh, studies from other countries suggest differences in physiological and behavioral characteristics may contribute to these differences [2528].
People with overweight/obesity or diabetes had higher odds of hypertension's prevalence and awareness. In the overall sample, about 25 and 10% people had overweight/obesity and diabetes, respectively. The overall prevalence rates of both conditions have increased in Bangladesh compared to 2011 [4, 18]. This rising trend has been observed in many other developing countries [2, 21, 29, 30]. Halting the rising burden of these conditions would be important not only for reducing hypertension burden but also for reducing the complications arising from themselves. Mortality, morbidity, and health care costs resulting from these conditions are also high [31, 32]. Although the higher awareness among people with diabetes or overweight/obesity could appear as a welcome finding, this finding should be interpreted with caution. As people with diabetes or overweight/obesity may need more health care visits compared to people without these, that could cause this higher awareness among them [33].
We also observed differences in prevalence and awareness according to wealth quintile and place of residence. A higher prevalence of hypertension among people with higher wealth status could be due to the fact that people with a relatively higher wealth quintile in Bangladesh follow more sedentary lifestyle that could contribute to the higher prevalence [9]. The urban-rural differences in prevalence of hypertension was substantially higher in 2011 and urban residents had about 1.5 times higher prevalence than rural people [4]. However, it was minimal in 2017–18 [4]. This indicates that the prevalence is rising rapidly in rural areas compared to urban areas. However, people with a lower wealth status and rural residence have relatively lower awareness level, this difference in awareness may result from differences in health care access, availability, and utilization behavior [4]. More than two-thirds of the people in Bangladesh live in rural regions, therefore, increasing awareness in rural regions is crucial [34]. We also observed some differences in prevalence and awareness of hypertension by division of residence, this may also be due to difference in socioeconomic status and health care utilization behavior according to division of residence [3].
This study has several strengths. First, the survey had a large sample that provided us adequate power for analysis. The survey covered rural and urban regions of all administrative divisions that made the survey nationally representative. BDHS 2017–18 had a high response rate and used standard validated methods that also increased the authenticity of our results [3].
However, limitations of this study also warrant discussion. As this was a cross-sectional study, the overall association may not be causal due to uncertainty about temporal association. Although standard guidelines recommend multiple longitudinal measurements in a clinical setting [21, 35], the BP was measured on a single day, this may have caused some non-differential misclassification. We did not adjust for some other known risk factors (e.g., lifestyle and dietary habits) due to limitations of the dataset [4, 21].

Conclusions

The prevalence of hypertension has increased but awareness and control level remained lower. To reduce the future burden associated with hypertension, it is essential to address the modifiable factors associated with higher prevalence, lower awareness, and poor control of it by effective awareness and control programs. Reducing prevalence and increasing control of hypertension among older people and males are important. Reducing prevalence of overweight/obesity and diabetes may reduce future burden of hypertension, as well as complications arising from it. Increasing awareness among younger people and prioritizing rural regions to raise awareness is essential.

Acknowledgements

The authors are thankful to the ICF International, Rockville, Maryland, USA for giving the permission to use the data.

Declarations

Secondary data from BDHS 2011 were analyzed for this study and the survey data was anonymized. The Institutional Review Boards (IRBs) of the ICF International, Rockville, Maryland, USA and Bangladesh Medical Research Council, Dhaka, Bangladesh approved the BDHS 2017–18 protocol. This dataset was available for scientific and academic use upon approval from the ICF International; the permission for using the data was obtained in December 2020. All participants provided informed consent to participate into the survey.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
12.
Zurück zum Zitat Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens. 1999;21:1009–60.CrossRef Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens. 1999;21:1009–60.CrossRef
13.
14.
Zurück zum Zitat WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet Lond Engl. 2004;363:157–63.CrossRef WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet Lond Engl. 2004;363:157–63.CrossRef
29.
Zurück zum Zitat NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet Lond Engl. 2017;390:2627–42.CrossRef NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet Lond Engl. 2017;390:2627–42.CrossRef
31.
Zurück zum Zitat Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, RJ MI, et al. Body-Mass Index and Mortality among 1.46 Million White Adults. N Engl J Med. 2010;363:2211–9.CrossRef Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, RJ MI, et al. Body-Mass Index and Mortality among 1.46 Million White Adults. N Engl J Med. 2010;363:2211–9.CrossRef
32.
Zurück zum Zitat Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–544. https://doi.org/10.1016/S0140-6736(16)31012-1.CrossRef Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–544. https://​doi.​org/​10.​1016/​S0140-6736(16)31012-1.CrossRef
33.
Zurück zum Zitat Finley CR, Chan DS, Garrison S, Korownyk C, Kolber MR, Campbell S, et al. What are the most common conditions in primary care? Systematic review. Can Fam Physician Med Fam Can. 2018;64:832–40. Finley CR, Chan DS, Garrison S, Korownyk C, Kolber MR, Campbell S, et al. What are the most common conditions in primary care? Systematic review. Can Fam Physician Med Fam Can. 2018;64:832–40.
35.
Zurück zum Zitat Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018:HYP.0000000000000065. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018:HYP.0000000000000065.
Metadaten
Titel
Prevalence, awareness, and control of hypertension among Bangladeshi adults: an analysis of demographic and health survey 2017–18
verfasst von
Gulam Muhammed Al Kibria
Rajat Das Gupta
Jannatun Nayeem
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
Clinical Hypertension / Ausgabe 1/2021
Elektronische ISSN: 2056-5909
DOI
https://doi.org/10.1186/s40885-021-00174-2

Weitere Artikel der Ausgabe 1/2021

Clinical Hypertension 1/2021 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.